ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2025
May Measurement Month 2022: an analysis of blood pressure screening results from Ghana.
Article in European heart journal supplements : journal of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The May Measurement Month (MMM) campaign was carried out in Ghana in 2022 with the aim of raising awareness of raised blood pressure (BP). Here, we report on the findings of the campaign. Adults aged ≥ 18 years were recruited opportunistically at Greater Accra, Eastern, Central, and Ashanti Regions of Ghana. Three seated BP readings were taken for each participant, along with completing a questionnaire on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg or being on antihypertensive medication. Controlled BP was defined as being on antihypertensive medication with a BP <140/90 mmHg. Multiple imputation was used to estimate any missing BP readings. In total, 3654 were screened, with a mean age of 38.3 years and 14.8% of whom were female. Of all participants, 1171 (32.0%) had hypertension, of whom 125 (10.7%) were aware, and 118 (10.1%) were on antihypertensive medication. Of those on antihypertensive medication, 23 (19.5%) had controlled BP, and of all participants with hypertension, 2.0% had controlled BP. The MMM campaign in Ghana identified a high proportion of participants with either untreated or inadequately treated hypertension. It is important to note that the annual BP screening campaign is a means to create awareness of the need to get screened and also identifies large numbers of individuals with raised BP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.